"Biofrontera AG (ISIN: DE000A4BGGM7), an international biopharmaceutical company, today announced its financial results for the first nine months ended September 30, 2024. Key Financial Figures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback